In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug.

WIN 51711 (5-[7-[4-(4,5-dihydro-2-oxazolyl)phenoxy]heptyl]-3-methylisoxazole), a new antipicornavirus drug, is a potent inhibitor of human entero- and rhinoviruses at concentrations not inhibitory to HeLa cell growth. In plaque reduction assays, WIN 51711 reduced plaque formation by 9 enteroviruses...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Otto, M J, Fox, M P, Fancher, M J, Kuhrt, M F, Diana, G D, McKinlay, M A
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1985
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180179/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2992365/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.27.6.883
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!